Sumary of Progress made toward understanding best non-invasive tests for NASH, fibrosis diagnosis:
- November 15, 2021 3 min read Source/Disclosures Published by: Source: Sanyal AJ.
- receiving grant/research support from Allergan, Boehringer Ingelheim, Intercept, Inventiva, Bristol Myers, Cirius Therapeutics, Cumberland, Echosens, Galectin, Galmed, Gilead, Intercept, Karius, Madrigal, Mallinckrodt, Merck, Novartis, Pfizer, Salix, Second Genome, Sequana and Thera technologies;
- Sanyal, MBBS, MD, professor in the department of internal medicine in the division of gastroenterology, hepatology and nutrition at Virginia Commonwealth University School of Medicine, said during The Liver Meeting Digital Experience.
- Sanyal noted this subset of patients was the only one to have a FibroScan (Echosens) performed within the pre-set time period.